MyDiabetesIQ - Phase 1
Research type
Research Study
Full title
MyDiabetesIQ: the use of artificial intelligence to enhance decision support for diabetes. Phase 1 – acceptability, usability and assessment of potential consequences.
IRAS ID
258231
Contact name
Nicholas Conway
Contact email
Sponsor organisation
NHS Tayside
Duration of Study in the UK
0 years, 4 months, 29 days
Research summary
Diabetes affects approximately 8% of the UK population and accounts for 10% of current NHS spending. Diabetes care in Scotland relies on a series of managed clinical networks supported by a national informatics platform, SCI-Diabetes. MyDiabetesMyWay (MDMW) is an interactive website for people with diabetes that also acts as a patient portal, allowing users to access their own clinical data stored within SCI-Diabetes. MDMW was developed within NHS Scotland where it is currently being used by approximately 30,000 people with diabetes. In addition, MDMW has been introduced by a number of clinical commissioning groups (CCGs) within NHS England. \nSCI-Diabetes provides clinicians with patient-specific tailored advice via an automated system that interrogates patient data, with limited functionality. MyDiabetes clinical has been developed to provide improved functionality that can be used as an adjunct to SCI-diabetes. The system aims to further improve clinical care at the patient level (via predictive models and algorithms of increased complexity) as well as at the population level (via improved data insights e.g. quality performance indicators).\nPatient engagement work has identified that MDMW users are also seeking additional functionality and advice regarding long term management. MyDiabetesIQ has been developed in response to this, to provide automated decision support that is highly tailored and specific to the individual user.\nThis study aims to evaluate MyDiabetesIQ platform design and development in terms of acceptability, usability and consequences (e.g. risk) for both patients and health care professionals (HCPs).\n
REC name
Yorkshire & The Humber - Bradford Leeds Research Ethics Committee
REC reference
19/YH/0344
Date of REC Opinion
4 Oct 2019
REC opinion
Favourable Opinion